NCT03632512 is a NA clinical trial of Hericium honey bolus in Tinnitus, sponsored by Providence University, Taiwan.

Who is sponsoring NCT03632512?

NCT03632512 is sponsored by Providence University, Taiwan.

What drugs are being tested in NCT03632512?

Interventions in NCT03632512: Hericium honey bolus, Placebo honey bolus.

Is NCT03632512 still recruiting?

NCT03632512 is currently status unknown. Last updated 15 August 2018.

Last reviewed 2018-08-15 · How we verify

NCT03632512

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Hericium Erinaceus on Clinical Patients With Hearing Impairment

Status unknown NA Last updated 15 August 2018

What this trial tests

NA trial testing Hericium honey bolus in Tinnitus in 80 participants. Status unknown.

Timeline

18 May 2018

Primary endpoint
17 January 2019

30 June 2020

Quick facts

Lead sponsor	Providence University, Taiwan
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	supportive care
Enrollment	80
Start date	18 May 2018
Primary completion	17 January 2019
Estimated completion	30 June 2020
Sites	1 location across Taiwan

Drugs / interventions tested

Hericium honey bolus
Placebo honey bolus

Conditions studied

Tinnitus — all drugs for Tinnitus →

Sponsor

Providence University, Taiwan

Who can join

Adults 50 to 79, any sex, with Tinnitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the effect of Hericium Erinaceus on clinical patients with hearing impairment and possible mechanisms. Subjects with hearing impairment will be enrolled and randomly divided into experimental or control group supplemented with Hericium Erinaceus (430 mg/kg/day) or placebo, respectively for eight months. Basic characteristics will be evaluated at baseline by questionnaire. The hearing, liver and kidney functions, and neurotrophic factors will be examined at baseline, 4th month and 8th month.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Tinnitus

Currently open trials in the same condition.

NCT07393880 — Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal Tinnitus · NA · recruiting
NCT07071480 — Noninvasive Therapy for Tinnitus · NA · recruiting
NCT07435298 — Navigated Repetitive TMS for Chronic Tinnitus · NA · recruiting
NCT07158034 — Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation · NA · recruiting
NCT07017998 — External Therapy for Tinnitus Management · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03632512 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Providence University, Taiwan
Last refreshed: 15 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03632512.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing